1-3 of 3
Reda Matuzeviciene, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Prospective Phase 2 Study to Assess Minimal Residual Disease after Ixazomib, Lenalidomide and Dexamethasone Treatment for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients

Raija Helena Silvennoinen, MDPhD, Anders Waage, MD PhD, Valdas Peceliunas, MD, Fredrik Schjesvold, MDPhD, Pekka Anttila, MD, Marjaana Säily, MD PhD, Mervi Putkonen, MD PhD, Kristina Carlson, MD, Einar Haukaas, MD, Marja Sankelo, MDPhD, Anu Partanen, MD PhD, Damian L. Szatkowski, MDPhDMSc, Markus Hansson, MD PhD, Anu Marttila, MD, Lucia Ahlberg, MD, Per Axelsson, MD, Birgitta Lauri, MD, Maija Helena Mikkola, MD, Conny Karlsson, MD, Johanna Abelsson, MD, Erik Ahlstrand, MD PhD, Anu Sikiö, MD, Monika Klimkowska, MD PhD, Reda Matuzeviciene, MD PhD, Mona Hoysaeter Fenstad, MD PhD, Sorella Ilveskero, MD PhD, Hareth Nahi, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-138643
Published: 2020
Journal Articles

Value of Flow Cytometry for MRD-Based Relapse Prediction in B-Cell Precursor Acute Lymphoblastic Leukemia in a Multi-Center Setting

Signe Modvig, MD PhD, Hans Madsen, Helene Hallböök, MD PhD, Sanna M. Siitonen, MD PhD, Liv T. N. Osnes, MD PhD, Susanne Rosthøj, PhD, Anne Tierens, MD PhD, Vesa Juvonen, PhD, Helen Vålerhaugen, Magnus Hultdin, MD PhD, Mats Ehinger, MD PhD, Anna Porwit, MD PhD, Reda Matuzeviciene, MD PhD, Mindaugas Stoskus, M Marincevic, PhD, Aili Lilleorg, PhD, Mervi Taskinen, MD PhD, Nina Toft, MD PhD, Ólafur Gísli Jónsson, MD PhD, Kaie Pruunsild, MD, Goda Elizabeta Vaitkeviciene, MD PhD, Kim Vettenranta, MD PhD, Bendik Lund, MD PhD, Jonas Abrahamsson, Kjeld Schmiegelow, Professor MD DMSc., Hanne Vibeke Marquart, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2755.
https://doi.org/10.1182/blood-2019-122311
Published: 2019
Journal Articles

Flow Cytometry Based MRD Monitoring Is an Accurate Risk Stratification Tool in Acute T-Lymphoblastic Leukemia

Signe Modvig, MD PhD, Hans O Madsen, Sanna M. Siitonen, MD PhD, Susanne Rosthøj, PhD, Vesa Juvonen, PhD, Liv T. N. Osnes, MD PhD, Helen Vålerhaugen, Magnus Hultdin, MD PhD, M Marincevic, PhD, Reda Matuzeviciene, MD PhD, Mindaugas Stoskus, Aili Lilleorg, PhD, Nina Toft, MD PhD, Ólafur G. Jónsson, MD, Kjeld Schmiegelow, MD, Hanne Vibeke Marquart, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 372.
https://doi.org/10.1182/blood.V130.Suppl_1.372.372
Published: 2017